evidence table

Bilberry Blood Glucose Meta-Analysis Evidence Table

Structured evidence table for Bilberry Blood Glucose Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Bilberry Blood Glucose Meta-Analysis1 2 3 Diabetes mellitus (DM) is a chronic condition characterized by elevated blood sugar levels due to reduced numbers or defects in islet β‐cells [].3Panchal Lakshay (2026)Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
Bilberry Blood Glucose Meta-AnalysisAccording to the World Health Organization, over the past few years (1980–2014), the prevalence of diabetes increased from 108 million to 422 million.3Panchal Lakshay (2026)Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
Bilberry Blood Glucose Meta-Analysis11 12 13 14 15 16 Approximately 5%–10% of diabetic patients experience secondary failure due to deterioration of beta‐cell activity, weight gain, poor medication, dietary modifications, reduced exercise, or illness [].3Panchal Lakshay (2026)Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
topicBilberry Blood Glucose Meta-Analysis
claim1 2 3 Diabetes mellitus (DM) is a chronic condition characterized by elevated blood sugar levels due to reduced numbers or defects in islet β‐cells [].
evidence level3
citationPanchal Lakshay (2026)
sourceExploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
topicBilberry Blood Glucose Meta-Analysis
claimAccording to the World Health Organization, over the past few years (1980–2014), the prevalence of diabetes increased from 108 million to 422 million.
evidence level3
citationPanchal Lakshay (2026)
sourceExploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials
topicBilberry Blood Glucose Meta-Analysis
claim11 12 13 14 15 16 Approximately 5%–10% of diabetic patients experience secondary failure due to deterioration of beta‐cell activity, weight gain, poor medication, dietary modifications, reduced exercise, or illness [].
evidence level3
citationPanchal Lakshay (2026)
sourceExploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideBilberry Blood Glucose Meta-analysis: What the Evidence SaysBilberry Blood Glucose Meta-analysis has 1 source documents in the current Migaku evidence datab...GuideChicory Root Fiber Blood Glucose Meta-analysis: What the Evidence SaysChicory Root Fiber Blood Glucose Meta-analysis has 2 source documents in the current Migaku evid...GuideRooibos Blood Glucose Meta-analysis: What the Evidence SaysRooibos Blood Glucose Meta-analysis has 1 source documents in the current Migaku evidence databa...GuideSea Buckthorn Blood Glucose Meta-analysis: What the Evidence SaysSea Buckthorn Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence...AnswerDoes Bilberry Blood Glucose Meta-Analysis work?Bilberry Blood Glucose Meta-Analysis has evidence relevant to strength of evidence and what the...AnswerIs Bilberry Blood Glucose Meta-Analysis safe?Bilberry Blood Glucose Meta-Analysis has evidence relevant to safety, limits, and clinician-disc...AnswerWhat does the evidence say about Bilberry Blood Glucose Meta-Analysis?Bilberry Blood Glucose Meta-Analysis has evidence relevant to benefits, uncertainty, and practic...

Source documents

  1. Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials